La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Reviva Pharmaceuticals a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Reviva Pharmaceuticals..

Reviva Pharmaceuticals (NASDAQ:RVPH) Azioni, Catena delle Opzioni

Reviva Pharmaceuticals

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Reviva Pharmaceuticals Holdings, Inc. - Common Stock

Reviva Pharmaceuticals Holdings Inc

Reviva Pharmaceuticals Holdings, Inc. - Warrants

TAMPA, Fla., April 23, 2025 /PRNewswire/ -- IntelAgree, a leading AI-powered contract lifecycle management (CLM) platform, is proud to announce its newest enterprise agreement with Casey's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CASY#NASDAQ">CASY</a>), a Fortune 500 company and the third-largest convenience store retailer and the fifth-largest pizza chain in the United States.
&nbsp;

News

CASY

IntelAgree Announces Enterprise Agreement With Casey's To Streamline Contract Management With AI

Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) shares are trading higher by 1.07% to $1,051.44 Tuesday, nearing record levels, as investors embrace the streaming giant&#8217;s <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44935008/netflix-stock-nears-all-time-high-whats-going-on">strong quarterly earnings</a> and its perceived insulation from global trade volatility.
What To Know: The stock&#8217;s upward momentum comes as broader markets rebound following reports that the Trump administration is considering scaling back tariffs on Chinese imports—a move aimed at de-escalating U.S.-China trade tensions, The Wall Street Journal <a href="https://www.wsj.com/politics/policy/white-house-considers-slashing-china-tariffs-to-de-escalate-trade-war-6f875d69">reported</a>.
The WSJ cited sources familiar with the matter who said the administration is weighing tariff reductions of up to 50%-65%, alongside a potential tiered system for future levies. While discussions remain fluid, investors <a href="https://www.benzinga.com/25/04/44944368/us-stocks-likely-to-open-higher-after-trump-administration-hints-at-a-deal-with-china-it-is-prudent-to-expect-continued-volatility-in-the-weeks-ahead-says-expert">welcomed signs of easing trade pressure</a> after weeks of escalating tariffs that had rattled global markets. 
China has since indicated a willingness to resume talks, though it warned against continued threats from Washington, per WSJ.
Meanwhile, Netflix&#8217;s strong first-quarter results continue to fuel investor optimism. The company posted revenue of $10.54 billion and earnings of $6.61 per share, both exceeding expectations. 
With limited exposure to tariffs and robust growth in memberships and ad revenue, analysts view Netflix as a <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44935008/netflix-stock-nears-all-time-high-whats-going-on">safe haven amid uncertainty</a>, with several raising price targets as high as $1,514.
<h2 class="wp-block-heading">How To Buy NFLX Stock</h2>
By now you're likely curious about how to participate in the market for Netflix &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Netflix, which is trading at $1,051.44 as of publishing time, $100 would buy you around 0.1 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, NFLX has a 52-week high of $1,064.97 and a 52-week low of $544.25.

NFLX

Netflix Stock Rallies On Last Week's Earnings Beat, Tariff Resilience As Markets Climb On Trade Optimism

Guggenheim analyst John Difucci reiterates Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) from Neutral to Neutral.

Reiteration

Analyst Ratings

MSFT

Guggenheim Reiterates Neutral on Microsoftto Neutral

JP Morgan analyst Samik Chatterjee maintains Calix (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CALX#NYSE">CALX</a>) with a Neutral and raises the price target from $34 to $38.

Price Target

CALX

JP Morgan Maintains Neutral on Calix, Raises Price Target to $38

Exxon Mobil Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) shares are trading higher by 3.4% to $107.52 over the past week, and are marginally lower during Wednesday&#8217;s session. The company finds itself in the middle of two recent, major shifts in the global energy landscape. 
What To Know: Amid U.S.-China trade tensions, Chinese refiners have reportedly slashed imports of U.S. oil <a href="https://www.benzinga.com/news/global/25/04/44860334/china-cuts-us-oil-purchases-by-90-boosts-imports-from-canada-to-new-heights">by 90% since 2023</a>, turning instead to Canadian crude. 
This follows the completion of Canada's Trans Mountain Pipeline Expansion, which has opened a new route to Asia. The strategic pivot reduces reliance on U.S. suppliers like Exxon, signaling a long-term change in North American oil dynamics.
Read Also: <a href="https://www.benzinga.com/personal-finance/25/04/44914351/heres-how-you-can-earn-100-in-passive-income-by-investing-in-exxon-mobil-stock">Here&#8217;s How You Can Earn $100 In Passive Income By Investing In Exxon Mobil Stock</a>
Meanwhile, Exxon's clean-energy partnerships face jeopardy as the U.S. Department of Energy considers <a href="https://www.benzinga.com/markets/25/04/44882365/trumps-energy-department-mulls-cutting-billions-in-clean-energy-funds-threatening-exxon-occidental-projects">cutting nearly $10 billion in federal funding</a>. The reductions, part of President Donald Trump's government efficiency campaign, could derail projects in carbon capture and hydrogen—core to Exxon's transition strategy. 
With Trump also reviving coal initiatives, the administration's moves are drawing backlash from clean-energy advocates and investors watching Exxon's climate positioning.
Exxon&#8217;s first-quarter earnings announcement is meanwhile scheduled for Friday, May 2nd, prior to market open. According to analyst consensus estimates, the company is expected to report EPS of $1.70 on revenue of $86.09 billion.
Read Also: <a href="https://www.benzinga.com/25/04/44948499/boeing-stock-jumps-after-q1-2025-results-production-expansion-plans-for-737-and-787">Boeing Clocks 18% Q1 Topline Growth, Plans Production Expansion For 737 And 787</a>
<h2 class="wp-block-heading">How To Buy XOM Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Exxon Mobil&#8217;s case, it is in the Energy sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, XOM has a 52-week high of $126.34 and a 52-week low of $97.80.

Exxon Mobil (XOM) Stock Caught In Crossfire Of Trade Tensions And US Clean Energy Cuts: What's Going On?

Corcept Therapeutics Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORT#NASDAQ">CORT</a>), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, will present data from its pivotal Phase 3 ROSELLA trial of relacorilant plus nab-paclitaxel in patients with platinum-resistant ovarian cancer at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. The data will be presented in a late-breaking oral presentation on Monday, June 2, 2025.
<ul>
<li>Title: ROSELLA: A Phase 3 Study of Relacorilant in Combination with Nab-Paclitaxel versus Nab-Paclitaxel Monotherapy in Patients with Platinum-Resistant Ovarian Cancer​ (GOG-3073, ENGOT-ov72)</li>
<li>Oral Abstract Session – Gynecologic Cancer</li>
<li>June 2, 2025, 8:00 AM – 11:00 AM CDT</li>
<li>Abstract Number: LBA5507</li>
</ul>
The ROSELLA trial is being conducted in collaboration with The GOG Foundation, Inc. (GOG-F), the European Network of Gynaecological Oncological Trial groups (ENGOT), the Asia-Pacific Gynecologic Oncology Trials Group (APGOT), the Latin American Cooperative Oncology Group (LACOG) and the Australia New Zealand Gynaecological Oncology Group (ANZGOG).

Biotech

General

CORT

Corcept To Present Late-Breaking Data From Pivotal Phase 3 ROSELLA Trial Of Relacorilant In Platinum-Resistant Ovarian Cancer At ASCO 2025

Guggenheim analyst Howard Ma reiterates Confluent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFLT#NASDAQ">CFLT</a>) with a Buy and maintains $38 price target.

CFLT

Guggenheim Reiterates Buy on Confluent, Maintains $38 Price Target

Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares are racing higher Wednesday on the heels of the company&#8217;s first-quarter results. CEO Elon Musk said on the call that he plans to begin scaling back his involvement with the Department of Government Efficiency, <a href="https://www.benzinga.com/25/04/44940401/elon-musk-says-hell-only-spend-day-or-two-per-week-on-government-matters-to-ensure-fraud-does-not-come-roaring-back-ceos-focus-to-shift-to-tesla-beginning-may">or DOGE, next month</a>.
What To Know: Tesla<a href="https://www.benzinga.com/news/earnings/25/04/44937440/tesla-q1-misses-estimates-as-tariff-pressures-weigh-on-outlook-lower-cost-evs-still-on-track"> reported</a> first-quarter revenue of $19.34 billion, missing analyst estimates of $21.35 billion, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. The company reported first-quarter earnings of 27 cents per share, missing analyst estimates of 41 cents per share. 
Total revenue fell 9% year-over-year as automotive revenue dropped 20% to $13.97 billion, due to a decline in deliveries, Model Y updates and lower average selling prices.
Tesla said it delivered 336,681 vehicles in the quarter, below analyst forecasts of 377,592. The company produced 362,615 vehicles in the first quarter, down from 433,371 vehicles in the prior year&#8217;s quarter.
Tesla refrained from providing guidance and said it will &#8220;revisit&#8221; 2025 guidance when the company reports second-quarter results. 
&#8220;While the current tariff landscape will have a relatively larger impact on our Energy business compared to automotive, we are taking actions to stabilize the business in the medium to long-term and focus on maintaining its health,&#8221; the company said.
Check This Out: <a href="https://www.benzinga.com/news/earnings/25/04/44943387/elon-musk-shares-fsd-update-at-tesla-earnings-call-10-to-20-model-ys-will-offer-paid-robotaxi-rides-in-june">Elon Musk Shares FSD Update At Tesla Earnings Call: &#8217;10 To 20&#8242; Model Ys Will Offer Paid Robotaxi Rides In June</a>
On a conference call following the print, Musk said that he would only spend &#8220;a day or two&#8221; each week working on DOGE initiatives. He told investors and analysts that he plans to allocate a lot more of his time to Tesla now that DOGE has been established. 
Wedbush analyst Dan Ives raised his price target on Tesla to $350 following the announcement, noting that the move from Musk helps to &#8220;remove the black cloud&#8221; that had been an overhang on the stock. 
Here&#8217;s a look at some other analyst changes following Tesla&#8217;s quarterly results:
<ul>
<li>Needham analyst Chris Pierce reiterated Tesla with a <a href="https://www.benzinga.com/analyst-stock-ratings">Hold rating</a>.</li>
</ul>
<ul>
<li>GLJ Research analyst Gordon Johnson maintained Tesla with a Sell and lowered the price target from&nbsp;$24.86&nbsp;to&nbsp;$19.05.</li>
</ul>
<ul>
<li>Baird analyst Ben Kallo maintained Tesla with an Outperform and lowered the price target from&nbsp;$370&nbsp;to&nbsp;$320.</li>
</ul>
<ul>
<li>Canaccord Genuity analyst George Gianarikas maintained Tesla with a Buy and lowered the price target from&nbsp;$404&nbsp;to&nbsp;$303.</li>
</ul>
Musk also said on the call that Tesla could produce a million Optimus bots per year as early as 2029. He also reaffirmed that the company&#8217;s Robotaxi pilot launch in Austin remains on schedule, which appears to be helping boost shares Wednesday morning. 
TSLA Price Action: <a href="http://benzinga.com/quote/tsla">Tesla shares</a> were up 6.80% at $254.15 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/management/25/04/44940011/benzinga-readers-predictions-for-tesla-q1-earnings-results-musks-announcements">Benzinga Readers&#8217; Predictions For Tesla Q1 Earnings Results, Musk&#8217;s Announcements</a></li>
</ul>
Photo: courtesy of Tesla.

Earnings

Guidance

Movers

TSLA

Tesla Stock Is Ripping Higher Wednesday: What's Driving The Action?

DA Davidson analyst Peter Winter maintains BOK Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOKF#NASDAQ">BOKF</a>) with a Buy and lowers the price target from $122 to $114.

BOKF

DA Davidson Maintains Buy on BOK Financial, Lowers Price Target to $114

Guggenheim analyst Howard Ma reiterates CommVault Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVLT#NASDAQ">CVLT</a>) from Neutral to Neutral.

CVLT

Guggenheim Reiterates Neutral on CommVault Systemsto Neutral

DA Davidson analyst Gary Tenner maintains Cadence Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CADE#NYSE">CADE</a>) with a Buy and lowers the price target from $42 to $37.

CADE

DA Davidson Maintains Buy on Cadence Bank, Lowers Price Target to $37

DA Davidson analyst Gary Tenner maintains East West Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) with a Buy and lowers the price target from $118 to $100.

EWBC

DA Davidson Maintains Buy on East West Bancorp, Lowers Price Target to $100

ASML Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) has outperformed the market over the past 15 years by 9.43% on an annualized basis producing an average annual return of 19.95%. Currently, ASML Holding has a market capitalization of $260.69 billion. 
Buying $100 In ASML: If an investor had bought $100 of ASML stock 15 years ago, it would be worth $1,545.39 today based on a price of $663.00 for ASML at the time of writing.
<h3>ASML Holding's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745422212_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

ASML

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today

Guggenheim analyst Curry Baker reiterates TKO Group Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TKO#NYSE">TKO</a>) with a Buy and maintains $175 price target.

Guggenheim Reiterates Buy on TKO Group Holdings, Maintains $175 Price Target

DA Davidson analyst Russell Gunther maintains Peoples Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEBO#NASDAQ">PEBO</a>) with a Buy and lowers the price target from $39 to $35.

PEBO

DA Davidson Maintains Buy on Peoples Bancorp, Lowers Price Target to $35

DA Davidson maintains United Community Banks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UCB#NYSE">UCB</a>) with a Buy and lowers the price target from $38 to $33.

DA Davidson Maintains Buy on United Community Banks, Lowers Price Target to $33

DA Davidson analyst Gary Tenner maintains Western Alliance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>) with a Buy and lowers the price target from $106 to $90.

DA Davidson Maintains Buy on Western Alliance, Lowers Price Target to $90

<figure class="wp-block-image aligncenter size-large"><img loading="lazy" decoding="async" width="1024" height="582" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/23030113/Rollercoaster-1024x582.jpg" alt="" class="wp-image-11367" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/23030113/Rollercoaster-1024x582.jpg 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/23030113/Rollercoaster-300x171.jpg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/23030113/Rollercoaster-768x436.jpg 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/23030113/Rollercoaster.jpg 1200w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h2 class="wp-block-heading">Here We Go Again&nbsp;</h2>
Warren Buffett&#8217;s mentor Benjamin Graham famously described the stock market as a mentally ill man (&#8220;Mr. Market&#8221;) who toggled between euphoria and despair. There&#8217;s an additional twist today, with Wall Street leaning left. Investment professionals on our X&nbsp;<a href="https://x.com/i/lists/1612691584155324417">Market Watchers list</a>&nbsp;alternate between rage against Trump and contempt for him.&nbsp;
We saw that today, as markets&nbsp;<a href="https://www.zerohedge.com/market-recaps/bitcoin-bid-gold-skids-stocks-bounce-amid-soft-data-slump">ripped higher</a>&nbsp;after hours on President Trump&#8217;s comments. ZeroHedge led with the news that Trump said he wouldn&#8217;t fire Fed Chairman Powell. But on our Market Watchers list, the focus was on tariffs. On Monday, they railed against Trump for wrecking the economy (as they saw it) with tariffs; on Tuesday, they mocked him for signaling some flexibility on them.&nbsp;
<h2 class="wp-block-heading">Tuesday&#8217;s Contempt For Trump</h2>
Here&#8217;s a small sample from our Market Watchers list: 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">And this is what it's like watching your opponent commit suicide <a href="https://t.co/TKcxZdO2FX">https://t.co/TKcxZdO2FX</a>
&mdash; Eliant Capital (@eliant_capital) <a href="https://twitter.com/eliant_capital/status/1914794195878879707?ref_src=twsrc%5Etfw">April 22, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x1f979; <a href="https://t.co/pmK5VzAAdm">pic.twitter.com/pmK5VzAAdm</a>
&mdash; Le Shrub&#x1f333;&#x1f525;&#x1f1fa;&#x1f1e6; (@agnostoxxx) <a href="https://twitter.com/agnostoxxx/status/1914799482513809503?ref_src=twsrc%5Etfw">April 22, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x1f602;&#x1f602;&#x1f602;&#x1f602;&#x1f602; <a href="https://t.co/PMInU7PZG8">pic.twitter.com/PMInU7PZG8</a>
&mdash; PiQ (@PiQSuite) <a href="https://twitter.com/PiQSuite/status/1914801599287058900?ref_src=twsrc%5Etfw">April 22, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">They looked you in the face and said it was Main Street's turn Then the The Treasury Secretary held a closed door meeting with Wall Street and said he "expected the situation to de-escalate" a day before Trump capitulated…for nothing in return
&mdash; BuccoCapital Bloke (@buccocapital) <a href="https://twitter.com/buccocapital/status/1914813577757667706?ref_src=twsrc%5Etfw">April 22, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
&#8220;Trump capitulated&#8221; because he said the final tariffs on China are going to be&nbsp;somewhere below 145%? We&#8217;ll see.
<h2 class="wp-block-heading">Maybe Trump&#8217;s Critics Are Right</h2>
Let&#8217;s concede the possibility that Trump is going to completely fold on tariffs. On the one hand, America&#8217;s trade deficits have been one of Trump&#8217;s two biggest political concerns since <a href="https://www.playboy.com/read/playboy-interview/playboy-interview-donald-trump-1990/">at least 1990</a> (his other concern: avoiding nuclear war). 
<figure class="wp-block-image aligncenter size-large"><a href="https://www.playboy.com/read/playboy-interview/playboy-interview-donald-trump-1990/"><img loading="lazy" decoding="async" width="1024" height="550" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/23032303/Trump-Playboy-1-1024x550.jpg" alt="" class="wp-image-11368" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/23032303/Trump-Playboy-1-1024x550.jpg 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/23032303/Trump-Playboy-1-300x161.jpg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/23032303/Trump-Playboy-1-768x412.jpg 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/23032303/Trump-Playboy-1.jpg 1200w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Also, Trump&#8217;s strongest support today comes from groups that don&#8217;t own a lot of stock, like young men (and very young women). 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Women R+4 among 18-21&#39;s is "the nightmare is just beginning"-tier for the left. <a href="https://t.co/TLzw3RhuRK">https://t.co/TLzw3RhuRK</a>
&mdash; Just Loki (@LokiJulianus) <a href="https://twitter.com/LokiJulianus/status/1914422701743382817?ref_src=twsrc%5Etfw">April 21, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
And, as we saw above, some Wall Streeters have contempt for him.&nbsp;
On the other hand&#8230;what? Trump is going to fold on his goal of reindustrializing America to please them? It&#8217;s possible, but we wouldn&#8217;t bet on that. Here&#8217;s what we have been betting on.&nbsp;
<h2 class="wp-block-heading">How We&#8217;re Playing The Market Roller Coaster&nbsp;</h2>
Our gameplan has basically been to buy the dips and fade the rallies. That&#8217;s what we&#8217;ve done so far this week.&nbsp;
On Monday, when the market tanked, we took profits on a couple of our bearish big tech bets:
Options
<ol>
<li>Puts on Apple, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>). Bought for $1.81 on <a href="https://portfolioarmor.substack.com/p/trade-alert-betting-against-the-bounce">4//14/2025</a>; sold for $2.71 on <a href="https://portfolioarmor.substack.com/p/trade-alert-betting-against-the-bounce/comment/110875000">4/21/2025</a>. Profit: 50%.</li>
<li>Puts on Nvidia Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>). Bought for $1.56 on <a href="https://portfolioarmor.substack.com/p/trade-alert-monster-rally">4/9/2025</a>; sold for $4.02 on <a href="https://portfolioarmor.substack.com/p/trade-alert-monster-rally/comment/110877872">4/21/2025</a>. Profit: 158%.</li>
</ol>
And added <a href="https://portfolioarmor.substack.com/p/trade-alert-bitcoin-bull">a couple of bullish bets</a> on Bitcoin-related names. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24AAPL&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$AAPL</a> <a href="https://twitter.com/search?q=%24NVDA&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$NVDA</a><a href="https://t.co/vJNbgejQ79">https://t.co/vJNbgejQ79</a>
&mdash; Portfolio Armor (@PortfolioArmor) <a href="https://twitter.com/PortfolioArmor/status/1914374100694315123?ref_src=twsrc%5Etfw">April 21, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
One of those bullish bets was on Semler Scientific, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMLR#NASDAQ">SMLR</a>), a profitable medical tech company that borrowed Michael Saylor&#8217;s Bitcoin Balance Sheet strategy. SMLR closed up 11.57% on Tuesday. 
On Tuesday, when the market rallied, we <a href="https://portfolioarmor.substack.com/p/trade-alert-tariff-fallout">added bearish bets</a> against two of the main vendors used by American small businesses that import from China. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24SPY&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$SPY</a><a href="https://t.co/7fiDKQNDFW">https://t.co/7fiDKQNDFW</a>
&mdash; Portfolio Armor (@PortfolioArmor) <a href="https://twitter.com/PortfolioArmor/status/1914712758643261451?ref_src=twsrc%5Etfw">April 22, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
If the market rallies again on Wednesday, we&#8217;ll be adding more short exposure. If you want a heads up when we do, you can subscribe to our trading Substack/occasional email list below.&nbsp;
And if you want to take advantage of the rally to hedge, 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24SPY&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$SPY</a> <a href="https://twitter.com/search?q=%24QQQ&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$QQQ</a> <a href="https://t.co/CE1xSWLwcH">https://t.co/CE1xSWLwcH</a>
&mdash; Portfolio Armor (@PortfolioArmor) <a href="https://twitter.com/PortfolioArmor/status/1914733519273594937?ref_src=twsrc%5Etfw">April 22, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
As a reminder, you can download the Portfolio Armor optimal hedging app by aiming your iPhone camera at the QR code below (or by <a href="https://apps.apple.com/us/app/portfolio-armor/id394951144">tapping here</a>, if you&#8217;re reading this on your phone). Our app can help you find the least expensive hedges given your risk tolerance and time frame.
<figure class="wp-block-image size-full"><a href="https://apps.apple.com/us/app/portfolio-armor/id394951144"><img loading="lazy" decoding="async" width="200" height="197" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/23033219/QR-Code-6.jpg" alt="" class="wp-image-11369" /></a></figure>
If you&#8217;d like to stay in touch
You can scan for optimal hedges for individual securities, find our current top ten names, and create hedged portfolios on <a href="https://portfolioarmor.com/">our website</a>. You can also follow Portfolio Armor on X <a href="https://twitter.com/portfolioarmor">here</a>, or become a free subscriber to our trading Substack using the link below (we&#8217;re using that for our occasional emails now).
<figure class="wp-block-image aligncenter size-full"><a href="https://portfolioarmor.substack.com/"><img loading="lazy" decoding="async" width="581" height="372" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/23033408/Widget-5.jpg" alt="" class="wp-image-11370" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/23033408/Widget-5.jpg 581w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/23033408/Widget-5-300x192.jpg 300w" sizes="(max-width: 581px) 100vw, 581px" /></a></figure>

Equities

Options

Opinion

Markets

AAPL

NVDA

SMLR

Bipolar Market Rips Higher On False Hope

WIIM

FUBO

FuboTV shares are trading lower following a Bloomberg report indicating the DOJ is probing the company's Disney deal amid competition concerns.

<a href="https://x.com/SenatorDurbin/status/1915062730580427059" title="https://x.com/SenatorDurbin/status/1915062730580427059">https://x.com/SenatorDurbin/status/1915062730580427059</a>

Macro Economic Events

Politics

Economics

Senator Dick Durbin Posts On X "The Decision Of Whether To Run For Re-election Has Not Been Easy. I Truly Love The Job Of Being A United States Senator. But In My Heart, I Know It's Time To Pass The Torch. So, I Am Announcing Today That I Will Not Be Seeking Re-election At The End Of My Term"

Press Releases

Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Health Care

Reviva Announces Positive Preliminary Topline Data for the Long-Term Open Label Extension Portion of the Phase 3 RECOVER Study Evaluating Brilaroxazine in Schizophrenia

Comments

Reviva Pharmaceuticals

Reviva Pharmaceuticals (RVPH) Opzioni

Reviva Pharmaceuticals (NASDAQ:RVPH) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO